Skip to main content

Tatsis Ourania's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed Feb 22, 2022

Accession no.
0000899243-22-007216
Filed
Feb 22, 2022
Trade date
Feb 17-18, 2022
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions. Open-market sales total $119.9K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tatsis OuraniaCIK 0001789815Officer (EVP, Chief Reg. & Quality Off.)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 17, 2022Common StockFTax withholdingDisposed−4,114$232.51−$956,546.1453,623Direct
Feb 18, 2022Common StockSSaleDisposed−218$229.52F2,F3−$50,035.3653,405Direct
Feb 18, 2022Common StockSSaleDisposed−101$230.42F3,F4−$23,272.4253,304Direct
Feb 18, 2022Common StockSSaleDisposed−80$232.04F3,F5−$18,563.253,224Direct
Feb 18, 2022Common StockSSaleDisposed−120$233.48F3,F6−$28,017.653,104Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Open market sales reported on this line occurred at a weighted average price of $229.52 (range $229.05 to $229.97).

Referenced by the price of 1 transaction in Table I.

F3

Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 4 transactions in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $230.42 (range $230.05 to $230.75).

Referenced by the price of 1 transaction in Table I.

F5

Open market sales reported on this line occurred at a weighted average price of $232.04 (range $231.89 to $232.13).

Referenced by the price of 1 transaction in Table I.

F6

Open market sales reported on this line occurred at a weighted average price of $233.48 (range $233.18 to $233.73).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)